From 5–9 March, we’ll be at AD/PD 2024 in Lisbon, to talk to researchers investigating Alzheimer’s Disease and Parkinson’s Disease, and to explore how fUS might be able to help them.
Neurodegenerative disorders present major challenges for patients, clinicians and society as a whole, and it’s long been an area of considerable interest for us. We’re therefore looking forward to attending AD/PD 2024, the ‘International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders’, which this year is being held in Lisbon, Portugal, from 5–9 March.
Naturally, we’re keen to attend the talks to uncover the latest trends, and have face-to-face conversations to find out more about the challenges faced by researchers. So please come along to Booth #15, where we’ll be happy to help you understand what fUS could offer your neurological research, and where you’ll also be able to take a look at our range of fUS probes.
In addition, our Head of Product Development, Jeremy Ferrier, will be giving a presentation on 6 March from 10:40–11:10, in Product Theater 01. Titled ‘Iconeus One: Pioneering real-time whole-brain imaging with functional ultrasound’, Jeremy will give an introduction to how fUS works and what it’s capable of, including what’s been achieved so far in preclinical research, and the projects we’re now involved with in the clinical arena.
If you’re coming along to AD/PD 2024, then we’d be pleased to meet up. If you’d like to schedule a chat with Jeremy or one of the Iconeus team, then let us know a suitable time, and we’ll be in touch!
